BrC1=CC[C@]23CC=C(Br)[C@H]4C[C@]2(COC3)C[C@@H]1O4
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?